After a one-year follow-up, 10 of 12 patients given the islet cell therapy zimislecel no longer required insulin. Vertex ...

The addition of anagliptin to insulin and metformin therapy may improve glycemic control in patients with type 2 diabetes while maintaining an acceptable safety profile.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

Conclusions Delays to hospital inpatient admission for patients in excess of 5 hours from time of arrival at the ED are associated with an increase in all-cause 30-day mortality. Between 5 and 12 ...

The ADA defines severe hypoglycemia as a medical emergency, and it may happen with blood sugar levels of 55 mg/dL and below. Still, your diabetes may vary, and what is considered low for someone ...

In a clinical trial led by University of Toronto researchers, an allogeneic stem cell–derived islet therapy (zimislecel) ...

However, major hypoglycemic events were significantly more common in patients with Type 1 rather than Type 2 diabetes (30 vs 16% of patients; p < 0.05), as also were minor hypoglycemic events ...

### Philosophy of the guideline ### Assessing patients Figure 1 Chart 1: Oxygen prescription for acutely hypoxaemic patients in hospital. ABG, arterial blood gas; COPD, chronic obstructive pulmonary ...

Learn the 5 warning signs of dumping syndrome after gastric surgery. Discover symptoms, causes, and life-changing management strategies for this condition.

Patient Who Survived Serious Head Injury Reveals Why He's 'Not Really Human Anymore' Published Jun 16, 2025 at 4:40 AM EDT. By . Tom Westerholm is a Life & Trends Reporter for Newsweek based in ...

A patient's experience highlights how fatty liver disease can suddenly accelerate after years of stability. Don't Miss. Travel. The optimal time to book a summer staycation in 2025 for 'better weather ...

‘I’m preparing for my next life by doing good’, says terminal liver cancer patient. Roger Tan, 48, was diagnosed with incurable liver cancer in late 2024 and given less than 12 months to live.